In experiments we conducted, HTS was used as a therapeutic agent to ameliorate secondary injury. It was chosen for its many positive attributes. In previous experiments from our laboratory, rodents (mice and rats) treated with HTS had improvements in motor scores, as well as in bladder function. 57, 58, 77, 78, 80, 84, 93 Other researchers have also been exploring the effects of HTS, noting its effects on adhesion molecules and leukocyte adhesion, as well as noting the effects of blocking adhesion molecules involved in the same pathway. 4, 5, 12, [37] [38] [39] [40] 61, 65, 69, 70, 81, 87 Hypertonic saline has also been extensively studied in the general surgery and trauma literature. It is favored for many abilities, including its role as a volume expander in shock and trauma, as a cheap and efficient fluid to transport, and as a fluid with favorable effects on the inflammatory cascade. 15, 20, 21, [23] [24] [25] 47, 62, 76, 83, 86 Factors such as the time of administration and the type of fluid for treatment have been studied as they relate to outcome measures for bladder recovery and cellular infiltration. Mice received 7.5% hypertonic (5 ml/kg) saline or normal saline (5 ml/kg) at either 3 or 24 hours intravenously after the initial injury.
Methods

Spinal Cord Injury
All procedures and protocols were approved by the Temple University Institutional Animal Care and Use Committee (No. 1319). The animals used were female C57Bl/6 mice (Taconic Inc.) weighing approximately 15-20 g. Procedures for acclimation, anesthesia, surgery, intravenous access, and care have been detailed. 58, 59 A group of 41 mice received a 60-kdyne force using an IH Impactor (PSI Inc.) On postinjury Day 1, mice with a total BMS (Basso Mouse Scale) 10,30 score ≤ 1 on either leg or a total BMS score of ≤ 2 were deemed to have received a clinically significant injury. Mice with either a score of ≤ 2 on the modified BBB Rating Scale 7-9 for leg locomotion or a total BBB score ≤ 4 were deemed to have received a clinically significant injury. Animals that had BBB scores outside these parameters were considered insufficiently injured and were excluded from the study. Eight such mice were excluded, and of these, 5 were the first to have undergone impact injury, which reflects a learning curve. Throughout the remaining testings, only 3 of the next 45 mice were excluded and 1 mouse died on postoperative Day 3.
Hypertonic Solution
The facial vein was identified and cannulated temporarily for intravenous injection. Details for this procedure have previously been published. 59 Hypertonic solution (7.5%, 5 ml/kg) was administered to the experimental mice, whereas NSS (0.9%, 5 ml/kg) was injected into the control groups.
Bladder Assessment
The method of bladder assessment has previously been described. 58 Mouse bladder function was assessed twice daily. All injured mice initially required twice daily credé maneuvers (manual bladder emptying). The emptied urine was weighed and followed as a total daily mass of expressed urine in milligrams. Animals that produced daily totals of less than 500 mg for 3 consecutive days (6 consecutive bladder emptying events and measurements) were considered to have recovered a functional bladder. The animals that were considered to have recovered bladder function continued to have their bladders palpated twice daily and were assigned sizes (small, ≤ 200 mg; medium, 300 mg; and large, ≥ 400 mg) corresponding to measured, expelled urine masses. With practice, a handler can accurately estimate bladder volume from palpated bladder size. Animals with large bladders (≥ 400 mg) for 3 consecutive measurements (1.5 days) were considered as having been erroneously assigned a functional bladder or possibly having lost a functional bladder and were returned to twice daily credé maneuver emptying. (This occurred only once over the course of the experiments, including instances in previously published data.)
Experimental Design and Statistical Analysis
Animals were assessed to 28 days and euthanized. Those that had injuries to their lower extremities (such as flank wound or toe injury) were excluded.
The model was that of a randomized blinded study. In this experiment, 4 groups of mice were involved: 11 mice treated at 3 hours with NSS, 10 mice treated at 24 hours with NSS, 10 mice treated at 3 hours with HTS, and 10 mice treated at 24 hours with HTS. Five mice from each group were euthanized at 14 days for histological analysis. An additional group of 9 mice with injury but no intravenous intervention was also included for comparison. Bladder recovery days were analyzed using a Cox proportional hazard model. A 2-way ANOVA with factors group × time was used to analyze the cellular infiltrates. Post hoc analyses were carried out using Bonferroni tests. All significance values were set at p < 0.05. A Spearman rank correlation was used to analyze the relationship between bladder recovery and cellular infiltrates.
Tissue Collection, Histology, and Quantification
Thirty-three of 41 mice were used for histological analysis 59 (8 specimens were lost in histological processing). Spinal cord tissue samples were preserved as in previously published reports. Briefly, spinal cord segments were removed and the dorsal roots marked with an indelible marker for segmental identification later. The spinal cord was then incubated for 3 days in 30% sucrose (at 4°C) before being cryo-sectioned into 12-mm crosssections. Subsequently, spinal cord sections were stained with H & E for visualization of cellular infiltrates.
To quantify changes in inflammatory cell infiltration within the spinal cord, H & E-stained slides were analyzed with an image analysis system (Bioquant II) using similar video-count thresholding methods as described by Elliott et al. 29 Video-count area refers to the number of pixels in a designated field that meet a user-defined criterion multiplied by the area of a pixel at the selected magnification (20 × objective and 350 magnification factor for this analysis). Threshold criteria for infiltrating immune cells included dark purple (hematoxylin) stained cells and excluded the lighter purple stained cells believed to be resident glia (Fig. 1) . The mean area fraction of thresholded reactive product in a selected region of interest, which included the dorsal column white matter, was determined by dividing the video-count area of pixels above background thresholds by the total number of pixels in the entire chosen image field. An irregular region of interest tool was used for each measurement. An EXFO XCite 120 Fluorescent illuminator (EXFO America) and a Retiga EXI cooled camera (QImaging) were used to maintain consistent illumination throughout the project. Group means and SEM (3-5 per group) are expressed as mean percentage of the area of immunoreactivity. All assessments and image analyses were performed blinded.
Results
Autonomic Testing (Bladder Functional Recovery)
Bladder functional recovery was significantly improved by both increased tonicity in treatment solution (HTS vs NSS) and in increased time interval to treatment (Fig. 2 upper) . All groups treated at 24 hours after injury had a higher likelihood of bladder function recovery than groups treated at 3 hours after injury. When the time of treatment is controlled, animals receiving HTS treatments were more likely to have functional bladder recovery than those receiving NSS. The percentage of animals with recovered bladder function in the HTS-treated group at 24 hours compared with the animals receiving no intravenous therapy (no treatment) was statistically significant (p < 0.05, Bonferroni posttests). It is interesting to note that the average day of recovery does not change across the treated groups, but is different from the untreated group (Fig. 2 lower) .
Histological Outcomes
The 33 mice were divided into 4 groups, each with 2 time periods. Groups consisted of 3 to 5 subjects. Mice received either NSS (0.9%, 5 ml/kg) or HTS (7.5%, 5 ml/ kg) at either 3 hours or 24 hours after a 60-kdyne SCI. Mice were then killed at 14 days or 28 days. The SCI produced significant cellular infiltration within the injury zone, as well as in affected gray and white matter areas in spinal cord segments in the region of the injury.
Cellular infiltration was measured in the spinal cord dorsal columns because, unlike humans, the cortical spinal tract in rodents is located in proximity to the dorsal columns. With cellular infiltration into the dorsal column measured at 14 and 28 days after injury across the 4 groups, a pattern again is noted. All HTS-treated groups improved over time in terms of cellular infiltration (Fig.  3 ). All groups that received NSS had increasing cellular infiltration from Day 14 to 28 postinjury.
After grouping similar outcomes, there is a weak, but significant, correlation (r = 0.3663 and p = 0.0392) using a Spearman rank correlation (with 1 outlier excluded) between the likelihood of bladder recovery and the presence of reduced cellular infiltration.
Discussion
The pathophysiology of SCI remains an active field of research.
6,33,35,49, 75, 90, 92 The search for converting the data into usable treatments has had some limited success in which current treatments remain controversial. Previous work in our laboratory on murine species (mice and rats) has demonstrated benefits of administering HTS in both head and spine trauma situations.
28, [57] [58] [59] 77, 78, 80, 84, 93 Using a mouse model of SCI, 58 we were able to demonstrate a significant improvement in motor outcomes as a result of treatment with HTS at 24 hours after injury. We observed that these mice appeared to have improved bladder recovery as well. One can conclude from these previous experiments that there is a relationship between HTS administration and improved neurological outcome in the mouse model.
In the current study, an interesting outcome involves bladder function. There were 5 treatment groups (no treatment, NSS at 3 hours, NSS at 24 hours, HTS at 3 hours, and HTS at 24 hours). These 5 groups were compared using a Cox proportional hazards model, rating the percentage of mice recovering over the course of the experiment (Fig. 2 upper, Table 1 ). As one moves from each treatment modality, the chance of bladder recovery increases by 66% (p < 0.05). This means that treatment with HTS compared with NSS at equivalent times always resulted in greater likelihood of bladder recovery. All mice that recovered bladder function tended to do so at approximately 7-9 days without significant difference between each group. Later times of treatment yielded greater likelihood of recovery. Interestingly, this holds true for animals receiving normal saline treatment as well. This suggests that there may be an aspect of volume restoration that may also be protective for SCI. This is consistent with previous work performed in our laboratory in rats. For example, rats receiving HTS after ischemic SCI have increased spinal cord blood flow and preservation of somatosensory evoked potentials. Higher spinal cord blood flow is noted than in cases treated with equivalent levels of isotonic saline. 84, 93 At 14 days, animals receiving HTS at 3 hours and NSS at 24 hours had the least infiltration of cells. It is surprising that HTS at 24 hours did not have the least cellular infiltration. This would have been the expected result, given the superior bladder recovery of the group, but the small sample size may be responsible for the results.
However, by 28 days, each group receiving HTS had a decreased cellular count while NSS-treated groups had an increased cellular count. Overall, there is a correla- Note that all groups treated with HTS have decreased cellularity from 14 to 28 days. The group with the highest cellularity received treatment attion, albeit weak, with cellular count and the likelihood of bladder recovery. This supports the idea that controlling cellular infiltration augments tissue preservation, leading to improved recovery. The invading leukocytes are known to arrive by 8-24 hours after injury, which would support why treatments coincident in timing with leukocyte arrival may be more effective.
It is also known that the blood-spinal cord barrier (analogous to the blood-brain barrier) is disrupted by injury and its reformation interacts with the delivery time of therapeutics. Bhardwaj et al.
11 studied cerebral infarct volume after treatment with HTS. In their study, rats receiving 7.5% HTS (10 ml/kg) immediately on reperfusion had an increase in cortical infarct volume after middle cerebral artery occlusion. Considering the possibility of damage from osmotically active sodium and water crossing a disrupted blood-brain barrier, the authors do suggest that the therapy may have different effects if administered later, when the blood-brain barrier has stabilized. There is evidence, however, that HTS solutions given after cortical impact injuries may improve outcome. 82 Related work with head contusion in rats by Elliott et al.
28,29 also reveals that the beneficial effects of HTS injection are dependent on administration time. Future studies testing for more time points of treatment such as 12, 36, or 48 hours would help to pinpoint an ideal administration time in a mouse model. Multiple injections (for example, at 12 and 24 hours) would also be considered in future work.
Restoration of bladder function likely involves the interaction between the micturition centers of the brain and the animal's bladder. It is known that only approximately 5% of the descending tracts need to be preserved to allow for a measure of functionality in the injured spinal cord. 34 Given the role for the bulbospinal tract to coordinate the detrusor muscle and the external urethral sphincter to permit murine urination, 22,60,66-68 it may be that increased preservation of these descending tracts by HTS administration at a time coincident with leukocyte migration explains the improvement in bladder function. Tract preservation was not measured directly in this pilot study, but would be a valuable histological outcome measure for future studies.
The timing of treatment may also relate to important clinical practices. The hydration protocol for the SCI mice is based on the protocol used at the University of California, Irvine, laboratories for the experimental treatment of SCI (unpublished data, Reeve-Irvine Research Center SCI Techniques Lab Manual, 2005). Perhaps the intravenous injection of volume, either HTS or NSS at 24 hours after injury, is protective by way of rehydrating at a time when the animal is most dehydrated. This suggests that the protocols used, while previously thought to be adequate for hydration (subcutaneous infiltration of NSS), may be inadequate for murine SCI. The HTS, while given in the same physical volume (5 ml/kg) as the normal saline, has enhanced volume restoration abilities. Note that the average mouse blood volume is 80 ml/kg. An injection of 5 ml/kg represents 1/16th of the animal's total intravascular volume. Because HTS effectively serves to expand circulating volume as much as 2 or 3 times the equivalent dose of NSS, 52 this would represent a 1/8 to nearly 1/4 the animal's blood volume. As such, some of the effect of the HTS may be as a volume expander. This would also explain how subjects receiving NSS at 24 hours could still show benefit, possibly by treating dehydration. Kølsen-Petersen 55 has raised doubts as to the clinical application of HTS. After a thorough review of the literature, the author originally stated that despite suggestive reports from cellular and animal studies with HTS, there are too few large clinical trials to draw a conclusion. However, in more recent papers he suggested that there may be a modest beneficial effect. 56 Certainly, more large-scale clinical trails are required to evaluate the utility of HTS as a treatment modality.
Other groups working with HTS have also reported positive results. In work by Deree and associates, 24 ,25 the addition of pentoxifylline, a nonspecific phosphodiesterase inhibitor, to HTS resuscitation has been observed to improve results in gut injury. Pentoxifylline is known to attenuate the neurophil oxidative burst and CD11b expression, both thought to cause damage to surrounding tissue in SCI. Some authors have noted improvement with HTS treatment, 20 but treatment with both substances together was even more effective. Similarly, work 40,87 by both Gris and Weaver has shown that modulation of neutrophil function through CD11 expression can improve functional outcome in rats. This is the same pathway that is affected by HTS in modulating neutrophil function. In fact, many authors are actively investigating the role of CD11 and the role of neutrophils in the pathophysiology of injury. 
Conclusions
This pilot study provides further evidence suggesting that HTS may be an effective therapeutic agent for the treatment of SCI and the timing of administration appears to be critical. Treatment with HTS after SCI was found to result consistently in improved bladder recovery both at 3 and 24 hours postinjury. At equivalent administration intervals, HTS, compared with NSS, improved the likelihood of bladder recovery. The treatment points chosen of 3 to 24 hours postinjury are reasonable in clinical practice. This suggests that HTS administration is a clinically relevant treatment for SCI suitable for future clinical trials. Multiple mechanisms are possible, including volume expansion, treatment of dehydration, amelioration of immunological response, and ultimately preservation of neural tissue. Future work is planned to further investigate the role of HTS and therapy administration time on the modulation of neutrophil invasion in the mouse model of SCI. Additional studies testing additional or multiple treatment times would help target the ideal treatment time for HTS. Larger studies with larger animal models, including clinical studies, would be necessary to fully determine the ideal use of this beneficial agent. 
